Bone Loss Treatment From Adjuvant Zoledronate Efficacy (BLAZE)
An Open,Multicentre,Prospective Study of Adjuvant Zoledronate Treatment in Osteoporosis Women With Breast Cancer
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from First Affiliated Hospital, Sun Yat-Sen University
See all terminations from First Affiliated Hospital, Sun Yat-Sen University
Listed as NCT01623908, this NA trial focuses on Bone Loss and Breast Neoplasms and remains terminated or withdrawn. Sponsored by First Affiliated Hospital, Sun Yat-Sen University, it has been updated 7 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2021 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital, Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .